Marina Leiva

Marina Leiva

Auto-generated profile, based on publicly available information

Marina Leiva

Molecular Biology of Reproduction and Development Research Group, Institut d’Investigacions Biomèdiques August Pi i Sunyer - Fundació de Recerca Clínic Barcelona (IDIBAPS-FRCB), Universitat de Barcelona

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2025 in Systems Biology in Reproductive Medicine
Verified
Journal Article
Closed access
MLMarina Leiva
Marina Leiva
MLMaria Lopez-Panades
Maria Lopez-Panades
DWDi Wang
Di Wang
MDMar Domingo-Lopez
Mar Domingo-Lopez
JCJudit Castillo
Judit Castillo
MJMeritxell Jodar
Meritxell Jodar
This comprehensive review reflects our current knowledge of viral infections in the context of assisted reproduction, highlighting the latest research and guidelines. It focuses on the major viral pathogens that have a significant impact on human reproduction. It examines their impact on both male and female reproductive systems, fertility outcomes, and pregnancy, with a particular emphasis on managing the risks of transmission in assisted reproductive technologies (ART). State-of-the-art screening protocols and preventive measures are outlined, highlighting the progress made in minimizing viral transmission and ensuring safe reproductive outcomes. By presenting the current landscape of viral management in reproductive health, this review underscores the need for continued vigilance, research, and innovation to face viral threats.

1 September 2024 in Systems Biology in Reproductive Medicine
Verified
Journal Article
Closed access
MJMeritxell Jodar
Meritxell Jodar
YBYasmina Barral
Yasmina Barral
MLMarina Leiva
Marina Leiva
JCJudit Castillo
Judit Castillo
RBRuth Barrio
Ruth Barrio
RORafael Oliva
Rafael Oliva
Despite that the SARS-CoV-2 pandemic has been controlled, it has affected a large proportion of the population, raising some concerns about potential sequelae in men at reproductive age. To contribute to the clarification of this issue, we performed a retrospective study comparing semen parameters values before and after confirmed SARS-CoV-2 infection in a large cohort of infertile men, compared to a control group that did not undergo SARS-CoV-2 infection. Wilcoxon test on paired samples and general linear regression model showed that SARS-CoV-2 infection has a detrimental effect on semen volume values (p < 0.005). However, semen volume seems to be significantly lower only during the first spermatogenic cycle after SARS-COV-2 infection (p < 0.005) and mainly in unvaccinated patients (p < 0.05). In addition, we detected alterations in progressive motility in patients infected with the alpha SARS-COV-2 strain (p < 0.05). In conclusion, our results show that although SARS-CoV-2 has a small effect on semen volume and sperm motility in infertile men, depending on the infectious strain or vaccination status, pre-infection values of semen parameters appear to be restored over one spermatogenic cycle after infection.

1 January 2026 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
MLMarina Leiva
Marina Leiva
JCJudit Castillo
Judit Castillo
DWDi Wang
Di Wang
GLGUIMERA LEAL
GUIMERA LEAL
RFRaquel Ferreti
Raquel Ferreti
MJMeritxell Jodar
Meritxell Jodar
Leiva M, et al. World J Mens Health. 2026 ;44:e31. https://doi.org/10.5534/wjmh.250385